Vascular Health and Exercise Performance of Overweight Children
NCT ID: NCT01729273
Last Updated: 2014-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2012-07-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Risk Factors, Body Composition, Fitness Levels And Quality Of Life In Overweight And Obese 8-17 Year Olds
NCT02024399
The Therapeutic Effect of Different Exercise Intensities on Weight Loss in Obese Children
NCT06205563
Weight Loss in Obese Children and Adolescents and Its Effect on Improvement of Destructive Changes in Blood Vessels
NCT00439933
Obesity Prevention for Pre-Adolescents
NCT00185978
Exercise and Diet Restriction on Cardiovascular Function in Obese Children and Adolescents
NCT03762629
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diet and Exercise Intervention
Tests will include EndoPAT analysis to assess endothelial function, applanation tonometry to assess arterial stiffness, carotid artery imaging to assess the wall thickness of the carotid arteries, exercise testing to assess the physical exercise capacity of these children and blood work to evaluate the lipid profile and inflammation status (CRP).
The Home Exercise Program will be 3 days a week for 12 weeks and participants will connect with the trainer to perform 45-60 minutes of a combination of strength training and aerobic activity via Skype. The Dietary Approaches to Stop Hypertension(DASH) eating pattern will be prescribed to all participants in the treatment group and specific strategies to achieve goals will be discussed weekly by the participant over the phone.
Diet and Exercise Intervention
Remote Dietary and Exercise Intervention Program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diet and Exercise Intervention
Remote Dietary and Exercise Intervention Program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Overweight (BMI \> 85 percentile)
* Interested in a 12 week ¬home exercise \& nutrition program
* Have computer \& internet access
* Can come to Lucile Packard Children's Hospital at Stanford for a 3-hour test at the start \& end of the study (so only twice!)
* Are able to come to testing after fasting overnight
* Do not smoke
* Do not take any medications
Exclusion Criteria
10 Years
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Seda Tierney, MD
Role: PRINCIPAL_INVESTIGATOR
Lucile Packard Children's Hospital - Pediatric Cardiology
Chau N Vu, BS
Role: STUDY_DIRECTOR
Lucile Packard Children's Hospital - Pediatric Cardiology
Katie Jo Buccola
Role: STUDY_CHAIR
Lucile Packard Children's Hospital - Pediatric Cardiology
Jeffrey Kazmucha
Role: STUDY_CHAIR
Lucile Packard Children's Hospital - Pediatric Cardiology
Laurie Steinberg
Role: STUDY_CHAIR
Stanford Prevention Research Center
Olga Ogareva
Role: STUDY_CHAIR
Lucile Packard Children's Hospital - Pediatric Cardiology
Inger Olson, MD
Role: STUDY_CHAIR
Lucile Packard Children's Hospital - Pediatric Cardiology
Chinyelu Nwobu, MD
Role: STUDY_CHAIR
Lucile Packard Children's Hospital - Pediatric Cardiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lucile Packard Children's Hospital at Stanford
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHRI-23724
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.